Open-Label Adjunctive Topiramate in the Treatment of Unstable Bipolar Disorder | Zendy

Roger S. McIntyre | Zendy; Rosanna Riccardelli | Zendy; Carin Binder | Zendy; Vivek Kusumakar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Open-Label Adjunctive Topiramate in the Treatment of Unstable Bipolar Disorder

Author(s) -

Roger S. McIntyre,

Rosanna Riccardelli,

Carin Binder,

Vivek Kusumakar

Publication year - 2005

Publication title -

the canadian journal of psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.68

H-Index - 117

eISSN - 1497-0015

pISSN - 0706-7437

DOI - 10.1177/070674370505000705

Subject(s) - topiramate , young mania rating scale , clinical global impression , bipolar disorder , adverse effect , mood , adjunctive treatment , mood stabilizer , rating scale , bipolar ii disorder , psychology , hamilton rating scale for depression , depression (economics) , mania , medicine , anesthesia , psychiatry , major depressive disorder , epilepsy , developmental psychology , alternative medicine , pathology , economics , macroeconomics , placebo

To assess open-label adjunctive topiramate in the treatment of outpatients with unstable bipolar disorder (BD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research